Caladrius Biosciences: Sicker Than Ever [Seeking Alpha]
Caladrius Biosciences, Inc. (CLBS)
Last caladrius biosciences, inc. earnings: 11/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
caladrius.com/investors/overview
Company Research
Source: Seeking Alpha
Summary Share Price Up on Good News Investor interest in Caladrius Biosciences ( CLBS ) was rekindled after two recent news events. In March, Caladrius acquired the global rights to Shire's ( SHPG ) CD34+ stem cell therapy to treat medically refractory angina. Shortly after, in June , the therapy was granted the Regenerative Medicine Advanced Therapy (RMAT) status by the FDA. Mr. Market reacted to this bit of news by lifting the share price CLBS up nearly 200%. A few lucky folks took some profits, but CLBS has nevertheless traded at an average price of $5.73 since July 1. This represents a sustained increase in share price of approximately 40%. CLBS spent an undisclosed but nominal upfront fee to Shire to acquire the CLBS14-RfA program and expended little capital to obtain the RMAT designation. The subsequent gyrations in share price represent market uncertainty around the value of these recent news events. Figure 1 - CLBS is trading ~40% higher after posit
Show less
Read more
Impact Snapshot
Event Time:
CLBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLBS alerts
High impacting Caladrius Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics